CIK 0001420720 · Non-accelerated filer<br>Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262797813
- Phone
- 302 355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Exit or restructuring costs · Executive or director change
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure
- NT 10-K Other NT 10-K
- 8-K Event Results of operations · Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · Unregistered share sale · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Shareholder vote results
Page 15 of 46 · 911 filings